Skip to main content
Log in

ER-D5 antigen in breast cancer

  • Rapid Communication
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

We measured an estrogen-receptor-associated protein (ER-D5), estrogen and progesterone receptors (ER;PgR) in samples obtained from 28 female patients with primary breast carcinoma. A correlation of r=0.79 was found between ER-D5 and ER values and between ER-D5 and PgR values in premenopausal woman. In postmenopausal women a correlation (r=0.75) was found only between ER-D5 and ER and not between ER-D5 and PgR. The measurement of this cytosolic protein may be a complementary tool in the management of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Coffer AI, Lewis KM, Brockas AJ, King RJB (1985) Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res 45:3685–3693

    Google Scholar 

  • Green GL, Jensen EV (1982) Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem 16:353–359

    Google Scholar 

  • Navarro MA, Villabona C, Pandadero M, Bonnin R (1987) Estrogen receptor by enzymeimmunoassay. Discordant findings with respect to dextran-coated charcoal. J Clin Oncol 5:(4)679

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Navarro, M.A., Guardia, M., Arranz, B. et al. ER-D5 antigen in breast cancer. J Cancer Res Clin Oncol 115, 290–291 (1989). https://doi.org/10.1007/BF00391705

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00391705

Keywords

Navigation